Novavax
- All
- News
- Videos
-
EU Regulator Backs Use Of Novavax Covid Shot As A Booster
The European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter.
-
Omicron-Specific Vaccine For India Coming Up: Adar Poonawalla To NDTV
The Serum Institute of India is working on an Omicron specific vaccine with Novavax, institute chief Adar Poonawalla told NDTV in an exclusive interview today. The vaccine can be expected by the year-end, he said.
-
US Experts Recommend Novavax COVID-19 Vaccine
A panel of experts convened by the US drug regulator on Tuesday recommended the Novavax Covid-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine hesitancy.
-
Novavax's Covid Vaccine Gets Emergency Use Nod For Kids Aged 12-17 In India
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.
-
Serum Institute Seeks Emergency Use Approval Of Covid Vaccine Covovax In South Africa
Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine
-
WHO Approves Novavax As 10th Authorised Covid Jab
The World Health Organization on Tuesday approved a Covid vaccine made by US pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light.
-
Covovax, Serum Institute's Covid Vaccine, Cleared By WHO
The World Health Organisation on Friday announced it has granted emergency approval to the Covid vaccine Covovax, Serum Institute of India's version of the Novavax vaccine.
-
Novavax Covid Vaccine Could Gain European, WHO Approval Next Week: Report
Novavax's covid vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the WHO, the Financial Times reported on Thursday
-
Japan Approves Moderna Covid Booster Shots Aiming To Increase Coverage
Japan on Thursday officially approved Moderna Inc's COVID-19 vaccine for its booster programme, while Novavax Inc filed for first approval of its shot in the country.
-
Adar Poonawalla Says Vaccine For Children In 6 Months
The world's largest producer of vaccines, Serum Institute of India (SII), hopes to launch the Novavax COVID-19 vaccine for children in six months, the firm's chief executive said on Tuesday.
-
Serum Institue Of India Exports First Novavax Shot
Serum Institute of India has sent doses of COVID-19 vaccine to Indonesia, in its first export of the Novavax shot, the government said on Wednesday.
-
Novavax Covid Vaccine Gets First Authorization, "More Expected" Says CEO
Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within "weeks," its CEO said after the shot received its first emergency use authorization (EUA) from Indonesia.
-
Novavax-Serum Institute Vaccine Gets Emergency Use Approval In Indonesia
Biotechnology firm Novavax Inc and its partner Serum Institute of India on Monday said they have received the first emergency use authorisation (EUA) for Novavax''s COVID-19 vaccine, in Indonesia.
-
Serum Institute Allowed To Enrol 7-11 Year-Olds In Covid Vaccine Trial
The country's drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
-
Novavax Begins Early-Stage Trial For Combined Influenza, Covid Vaccines
US firm Novavax on Wednesday announced that it has initiated an early stage to evaluate the safety and immunogenicity of a combined flu Novavax' seasonal influenza and COVID-19 vaccines.
-
EU Regulator Backs Use Of Novavax Covid Shot As A Booster
The European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter.
-
Omicron-Specific Vaccine For India Coming Up: Adar Poonawalla To NDTV
The Serum Institute of India is working on an Omicron specific vaccine with Novavax, institute chief Adar Poonawalla told NDTV in an exclusive interview today. The vaccine can be expected by the year-end, he said.
-
US Experts Recommend Novavax COVID-19 Vaccine
A panel of experts convened by the US drug regulator on Tuesday recommended the Novavax Covid-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine hesitancy.
-
Novavax's Covid Vaccine Gets Emergency Use Nod For Kids Aged 12-17 In India
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.
-
Serum Institute Seeks Emergency Use Approval Of Covid Vaccine Covovax In South Africa
Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine
-
WHO Approves Novavax As 10th Authorised Covid Jab
The World Health Organization on Tuesday approved a Covid vaccine made by US pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light.
-
Covovax, Serum Institute's Covid Vaccine, Cleared By WHO
The World Health Organisation on Friday announced it has granted emergency approval to the Covid vaccine Covovax, Serum Institute of India's version of the Novavax vaccine.
-
Novavax Covid Vaccine Could Gain European, WHO Approval Next Week: Report
Novavax's covid vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the WHO, the Financial Times reported on Thursday
-
Japan Approves Moderna Covid Booster Shots Aiming To Increase Coverage
Japan on Thursday officially approved Moderna Inc's COVID-19 vaccine for its booster programme, while Novavax Inc filed for first approval of its shot in the country.
-
Adar Poonawalla Says Vaccine For Children In 6 Months
The world's largest producer of vaccines, Serum Institute of India (SII), hopes to launch the Novavax COVID-19 vaccine for children in six months, the firm's chief executive said on Tuesday.
-
Serum Institue Of India Exports First Novavax Shot
Serum Institute of India has sent doses of COVID-19 vaccine to Indonesia, in its first export of the Novavax shot, the government said on Wednesday.
-
Novavax Covid Vaccine Gets First Authorization, "More Expected" Says CEO
Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within "weeks," its CEO said after the shot received its first emergency use authorization (EUA) from Indonesia.
-
Novavax-Serum Institute Vaccine Gets Emergency Use Approval In Indonesia
Biotechnology firm Novavax Inc and its partner Serum Institute of India on Monday said they have received the first emergency use authorisation (EUA) for Novavax''s COVID-19 vaccine, in Indonesia.
-
Serum Institute Allowed To Enrol 7-11 Year-Olds In Covid Vaccine Trial
The country's drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
-
Novavax Begins Early-Stage Trial For Combined Influenza, Covid Vaccines
US firm Novavax on Wednesday announced that it has initiated an early stage to evaluate the safety and immunogenicity of a combined flu Novavax' seasonal influenza and COVID-19 vaccines.
